Form 4: Entrada Therapeutics CFO Kory James Wentworth Reports Stock Sales to Cover Tax Obligations
SEC Form 4 Filing
Kory James Wentworth, CFO of Entrada Therapeutics, sold shares of common stock between September 3rd and September 5th, 2024, to cover tax withholding obligations upon the vesting of restricted stock units.
Summary
- Kory James Wentworth, the Chief Financial Officer of Entrada Therapeutics, Inc. (TRDA), reported the sale of common stock between September 3rd and September 5th, 2024.
- The sales were executed to cover minimum statutory tax withholding obligations arising from the vesting and settlement of restricted stock units.
- These sales were not discretionary trades but were mandated by a sell-to-cover provision in the award agreement.
- On September 3rd, 462 shares were sold at a weighted average price of $15.7611, 149 shares at $16.9255, and 14 shares at $17.702.
- On September 4th, 941 shares were sold at a weighted average price of $15.4234.
- On September 5th, 165 shares were sold at a weighted average price of $15.126.
- Following these transactions, Wentworth directly owns 79,681 shares of Entrada Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to stock sales for tax obligations, which is neutral in sentiment.
Industry Context
Form 4 filings are standard practice for company insiders reporting transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The stock sales could have a minor dilutive effect on existing shareholders, but the impact is likely minimal given the relatively small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| 09/03/2024 | Date of first reported transaction: sale of common stock. |
| 09/04/2024 | Date of second reported transaction: sale of common stock. |
| 09/05/2024 | Date of third reported transaction: sale of common stock. |
| 09/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.